Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Dupilumab vs Omalizumab for Nasal Polyps
Recruiting2 awardsPhase 4
Tampa, Florida
This trial is comparing the efficacy of two drugs, dupilumab and omalizumab, in reducing polyp size, improving sense of smell, and reducing symptoms of CRSwNP. The trial will also evaluate the effect of the drugs on quality of life, asthma control, and safety.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.